Epidemic and non-epidemic Kaposi's sarcoma: Diagnosis, staging and treatment

Critical Reviews in Oncology/Hematology

Volumn 24, Issue 3, 1996, Pages 153-163

  Iwamasa, Teruo ^a   Chinen, Katsuya ^a   Hirayasu, Tsuneo ^a   Nakazato, Iwao ^a   Tsuhako, Kyoko ^a   Kamada, Yosihiko ^a   Miyamoto, Kanji ^b  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; GLUCAN; PENTOSAN POLYSULFATE; VINBLASTINE; VINCRISTINE;

CANCER STAGING; HERPES VIRUS; HUMAN; KAPOSI SARCOMA; REVIEW;

EID: 0030297128     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/1040-8428(96)00207-7     Document Type: Review

References (50)

1. [1] Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syphil 4: 265-273, 1872.
2. [2] Lee WA, Hutchins GM. Cluster analysis of the metastatic patterns of human immunodeficiency virus associated Kaposi's sarcoma. Hum Pathol 23: 306-311, 1992.
3. [3] Guarda LG, Silva EG, Ordonez NG, Smith JL. Factor VIII in Kaposi's sarcoma. Am J Clin Pathol 76: 197-200, 1981.
4. [4] Rutgers JL, Wieczorek R, Bonetti F, Kaplan KL, Posnett DN, Friedman-Kien AE, Knowles II DM. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin. Am J Pathol 122: 493-499, 1986.
5. [5] Hashimoto H, Muller H, Falk S, Stutte HJ. Histogenesis of Kaposi's sarcoma associated with AIDS: a histologic, immunohistochemical and enzyme histochemical study. Path Res Pract 182: 658-668, 1987.
6. [6] Scully PA, Steinman HK, Kennedy C, Trueblood K, Frisman, DM, Voland JR. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. Am J Pathol 130: 244-251, 1988.
7. [7] Kamada Y, Iwamasa T, Miyazato M, Sunagawa K, Kunishima N. Kaposi sarcoma in Okinawa. Cancer 70: 861-868, 1992.
8. [8] Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the autogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 127: 145-155, 1992.
9. [9] Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242: 430-433, 1988.
10. [10] Kumar D, Sanchez RL, Kumar S. Dendrocyte population in cutaneous and extracutaneous Kaposi's sarcoma. Am J Dermatopathol 14: 298-303, 1992.
11. [11] Werner S, Hofschneider PH, Roth WK. Cells derived from sporadic and AIDS-related Kaposi's sarcoma reveal identical cytochemical and monoclonal properties in vitro. Int J Cancer 43: 1137-1144, 1989.
12. [12] Dell Bovi P, Basilico C. Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad Sci USA 84: 5660-5664, 1987.
13. [13] Delli Bovi P, Culatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, Rifkin DB, Basilico C. Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol 8: 2933-2941, 1988.
14. + T cells. Science 242: 246-249, 1988.
15. [15] Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243: 223-226, 1989.
16. [16] Weich HA, Salahuddin SZ, Gill P, Nakamura S, Gallo RC, Folkmann J. AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. Am J Pathol 139: 1251-1258, 1991.
17. [17] Nakamura S, Sakurada A, Salahuddin SZ, Osada Y, Tanaka NG, Sakamoto N, Sekiguchi M, Gallo RC. Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex. Science 255: 1437-1440, 1992.
18. [18] Sturzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 89: 7046-7050, 1992.
19. [19] Weindel K, Marme D, Weich HA. AIDS-associated growth factor. Biochem Biophys Res Commun 183: 1167-1174, 1992.
20. [20] Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86, 1990.
21. [21] Su IJ, Kuo TT, Wu SY, Hung IJ. Lymphadenopathic type of Kaposi's sarcoma presenting with generalized petechial hemorrhages. A case report from Taiwan. Cancer 54: 948-950, 1984.
22. [22] Hocking W, Lazar G, Goldsmith M, Foreman S. Kaposi's sarcoma associated with hairy cell leukemia, immune thrombocytopenic and opportunistic infection. Cancer 54: 110-113, 1984.
23. [23] Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339: 632-635, 1992.
24. [24] Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869, 1994.
25. [25] Taylor JF, Templeton AC, Vogel CL, Zieger JL, Kyalwazi SK. Kaposi's sarcoma in Uganda: clinicopathological study. Int J Cancer 8: 122-135, 1971.
26. [26] Schmid H. Kaposi's sarcoma in Tanzania: a statistical study of 220 cases. Trop Geogr Med 25: 266-276, 1973.
27. [27] Klepp O, Dahl O, Stenwig JT. Association of Kaposi's sarcoma and prior immunosuppressive therapy. A 5-year material of Kaposi's sarcoma in Norway. Cancer 42: 2626-2630, 1978.
28. [28] Uchima E, Kajiwara M, Mukai T, Ohno Y, Nagamori H, Matsumoto H, Miyazaki T, Suzuki K, Ito S. Distribution of GM allotypes among the three populations of the Miyako Islands in Okinawa. Jpn J Legal Med 43: 310-314, 1989.
29. [29] Contu L, Cerimele D, Pintus A, Cottoni F, LaNasa G. HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens 23: 240-245, 1984.
30. [30] Pollack MS, Safai B, Myskowski PI, Gold JWM, DuPont B. Frequency of HLA and GM immunogenetic Kaposi's sarcoma. Tissue Antigens 21: 1-8, 1983.
31. [31] Jones RR, Jones EW. The histogenesis of Kaposi's sarcoma. Am J Dermatopathol 8: 369-370, 1986.
32. [32] Dorfman RD, Wood GS, Beckstead JH. Histogenesis. In: Ziegler JL, Dorfman RD, eds. Kaposi's Sarcoma: Pathophysiology and Clinical Management. New York: Marcel Dekker, 1988; 71-112.
33. [33] Jones RR, Orchard G, Zelger B, Jones EW. Immunostaining for CD 31 and CD 34 in Kaposi sarcoma. J Clin Pathol 48: 1011-1016, 1995.
34. [34] Miyazato M, Fukuda M, Iwamasa T. Growth characteristics of retinal capillary endothelial cells compared with pulmonary vein endothelial cells in culture. The effect of pericytes on differentiation of endothelial cells. Acta Pathol Jpn 41: 133-142, 1991.
35. [35] Miyamoto K, Tomita N, Hayashi K, Akagi T. Transformation of animal cells with human T-cell leukemia virus type II. Jpn J Cancer Res 81: 720-722, 1990.
36. + T-cells through syncytium formation by HTLV-II. Jpn J Cancer Res 82: 1178-1183, 1991.
37. [37] Safai B. Kaposi's sarcoma: a review of classical and epidemic forms. Ann NY Acad Sci 437: 373-381, 1984.
38. [38] Safai B. Pathophysiology and epidemiology of epidemic Kaposi's sarcoma. Semin Oncol 14: 7-12, 1987.
39. [39] Blumenfeld W, Egbert BM, Sagebiel RW. Differential diagnosis of Kaposi's sarcoma. Arch Pathol Lab Med 109: 123-127, 1985.
40. [40] Weiss SW, Enzinger FM. Spindle cell hemangioendothelioma. A low-grade angiosarcoma resembling a cavernous hemangioma and Kaposi's sarcoma. Am J Surg Pathol 10: 521-530, 1986.
41. [41] Enzinger FM, Weiss SW. Hemangioendothelioma: vascular tumors of intermediate malignancy. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors, 3rd edn. St. Louis: Mosby-Year Book Inc., 1995; 627-640.
42. [42] Templeton AC. Pathology. In: Ziegler JL, Dorfman RF, eds. Kaposi's sarcoma: Pathophysiology and Clinical Management. New York: Marcel Dekker, 1988; 23-70.
43. [43] Fayemi AO, Toker C. Nodal angimatosis. Arch Pathol 99: 170-172, 1975.
44. [44] Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 14: 13-18, 1987.
45. [45] Krigel RL, Laubenstein LJ, Muggia FM. Kaposi's sarcoma: a new staging classification. Cancer Treat Rep 67: 531-534, 1983.
46. [46] Volberding PA. The role of chemotherapy for epidemic Kaposi's sarcoma. Semin Oncol 14: 23-26, 1987.
47. [47] Krown SE. The role of interferon in the therapy of epidemic Kaposi's sarcoma. Semin Oncol 14: 27-33, 1987.
48. [48] Hill DR. The role of radiotherapy for epidemic Kaposi's sarcoma. Semin Oncol 14: 19-22, 1987.
49. [49] Chang L-FL, Reddy S, Shidnia H. Comparison of radiation therapy of classic and epidemic Kaposi's sarcoma. Am J Clin Oncol 15: 200-206, 1992.
50. [50] Biesert L, Schartono H, Winkler I, Meichsner C, Helsberg M, Hewlett G, Klimetzek V, Molling K, Schlumberger HD, Schrinner E, Brede H-D, Rubsamen-Waigmann H. Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound. AIDS 2: 449-457, 1988.